收藏切换
Progress in study on enteritis caused by immune checkpoint inhibitors
收藏切换
Yu-ting WANG, Xin-ge LÜ, Chen PAN, Yi WU, Xiang-li CUI*
Chinese Journal of New Drugs | 2026, 35(18) : 1939 - 1943
Less
收藏切换
Chinese Journal of New Drugs | 2026, 35(18): 1939-1943
Progress in study on enteritis caused by immune checkpoint inhibitors
Full
Yu-ting WANG, Xin-ge LÜ, Chen PAN, Yi WU, Xiang-li CUI*
Affiliations
  • Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
Published: 2026-09-30 doi: 10.20251/j.cnki.1003-3734.2026.18.005
Outline
收藏切换

Immune checkpoint inhibitors (ICIs) are the core of tumour immunotherapy, but they are prone to induce immune-associated adverse events (irAEs). ICIs-associated enterocolitis is the most common and important irAE in the gastrointestinal tract, accounting for 37% of the fatal irAEs, which seriously affects the treatment and prognosis of patients. The incidence varies by drug: 7.7%~15% for cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) inhibitors, 1%~2% for programmed death-ligand 1(PD-1/PD-L1) inhibitors single therapy, rising to 13.9%~40% for combination therapy. The time of onset is earlier for CTLA-4 inhibitors (1~3 months) and later for PD-1/PD-L1 inhibitors (3~6 months). Risk factors include high-dose ICIs, combination therapy, previous history of IBD, intestinal dysbiosis, NSAIDs use, and genetic polymorphisms. Clinical manifestations are centered on diarrhiea, which can lead to complications such as intestinal perforation. The diagnosis is multifactorial, with biomarkers such as fecal calproteatin being important. The treatment is graded, with biologics improving difficult-to-treat cases, and the majority of patients with enterocolitis have a better prognosis.

immune checkpoint inhibitors  /  enterocolitis  /  immune-related adverse events  /  immunotherapy
王雨婷, 吕欣鸽, 潘晨, 武一, 崔向丽. 免疫检查点抑制剂引起肠炎研究进展. 中国新药杂志, 2026 , 35 (18) : 1939 -1943 . DOI: 10.20251/j.cnki.1003-3734.2026.18.005
Yu-ting WANG, Xin-ge LÜ, Chen PAN, Yi WU, Xiang-li CUI. Progress in study on enteritis caused by immune checkpoint inhibitors[J]. Chinese Journal of New Drugs, 2026 , 35 (18) : 1939 -1943 . DOI: 10.20251/j.cnki.1003-3734.2026.18.005
Year 2026 volume 35 Issue 18
42
6
Cite this Article
BibTeX
Article Info
doi: 10.20251/j.cnki.1003-3734.2026.18.005
  • Online Date:2026-10-26
  • Published:2026-09-30
Article Data
Affiliations
History
  • Accepted:2025-10-30
Funding
Affiliations
    Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/10.20251/j.cnki.1003-3734.2026.18.005
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT